Bay Street News, January 7th, 2019

APADAZ® Now Approved in Three Dosage Strengths, Providing Greater Flexibility to Prescribers Through Additional Dosing Options CORALVILLE, Iowa, Jan. 07, […]

Presentation scheduled for Thursday, January 10, 2019 at 10:00 AM PT NEW YORK, Jan. 07, 2019 (GLOBE NEWSWIRE) — TG […]

DALLAS, Jan. 07, 2019 (GLOBE NEWSWIRE) — Primoris Services Corporation (NASDAQ Global Select: PRIM) (“Primoris” or “Company”) today announced a […]

TORONTO, Jan. 07, 2019 (GLOBE NEWSWIRE) — Datametrex AI Limited (the “Company” or “Datametrex”) (TSXV: DM, FSE: D4G) announces that […]

TORONTO, Jan. 07, 2019 (GLOBE NEWSWIRE) — VitalHub Corp. (the “Company”) (TSXV: VHI) is pleased to announce that the Province […]

Volumes of 2.0 million tons sold in 4Q 2018 vs. 2.8 million tons in 3Q 2018 Second Kermit production facility […]

IRVING, Texas, Jan. 07, 2019 (GLOBE NEWSWIRE) — Reata Pharmaceuticals, Inc. (Nasdaq: RETA), a clinical-stage biopharmaceutical company, today announced the […]

RAMSEY, N.J. and BOCA RATON, Fla., Jan. 07, 2019 (GLOBE NEWSWIRE) — ADMA Biologics, Inc. (NASDAQ: ADMA) (“ADMA” or the […]

Voyager to increase the size of RESTORE-1 Phase 2 trial and to conduct a similarly-sized RESTORE-2 Phase 3 trial VY-AADC […]

Industry leader brings global expertise, including as Shire’s former Global Head of Research and Development, to help further accelerate momentum […]